Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225832 · ClinicalTrials.gov registry record · NA
A Cognitive Behavioral Therapy Group Intervention to Increase HIV Testing and PrEP Use Among Latinx Sexual Minority Men
A NA study, sponsored by RAND.
- Terminated
- Registry status
- NA
- Development phase
- 289
- Enrollment target
NCT04225832: Clinical Trial NA study, sponsored by RAND.
NCT04225832 is a NA study that was terminated before completion, run by RAND. The registered enrollment target is 289 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04225832, a NA study, was terminated before completion, sponsored by RAND.
- TERMINATED
- Registry status
- NA
- Development phase
- 289 participants
- Enrollment target
Study Summary
This study consists of a randomized controlled trial (RCT) of a multi-session cognitive behavior therapy (CBT) group intervention that aims to improve HIV outcomes by increasing adaptive, effective coping responses to stigma from intersectional identities related to ethnicity, immigration status, sexual minority identity, HIV status, and PrEP use among Latinx sexual minority men (SMM).
Primary Outcome
Participants report being tested for HIV at least once in the 12 months after baseline
Interventions
- BEHAVIORAL CBT Coping Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2020-01-20 |
| Est. Completion | 2024-11-27 |
| Phase | NA |
Why NCT04225832 stopped before completion
NCT04225832 is an interventional study that assigns participants to a tested intervention. The registered 289 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which CBT Coping Intervention is the first listed.
NCT04225832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04225832 about?
NCT04225832 is a clinical study titled "A Cognitive Behavioral Therapy Group Intervention to Increase HIV Testing and PrEP Use Among Latinx Sexual Minority Men". This study consists of a randomized controlled trial (RCT) of a multi-session cognitive behavior therapy (CBT) group intervention that aims to improve HIV outcomes by increasing adaptive, effective coping responses to stigma from intersectional identities related to ethnicity, immigration status, se...
What is the current status of trial NCT04225832?
This trial is currently terminated. It is a NA study. The enrollment target is 289 participants. The study started on 2020-01-20. Estimated completion is 2024-11-27.
What interventions are being tested in trial NCT04225832?
The interventions under investigation include: CBT Coping Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04225832?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04225832's enrollment target sits among peer trials
289 376th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465199 · 289 participants · Phase 1
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI